Skip to product information
1 of 1

Elabscience

SKU:PKSV030181

Recombinant HIV-1 (group M, subtype A, isolate 92RW020) Envelope glycoprotein gp160 Protein (gp120 subunit) (His Tag)

Recombinant HIV-1 (group M, subtype A, isolate 92RW020) Envelope glycoprotein gp160 Protein (gp120 subunit) (His Tag)

Regular price $855.00 USD
Regular price Sale price $855.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant HIV-1 (Group M, Subtype A, Isolate 92RW020) Envelope Glycoprotein GP160 Protein (GP120 Subunit) (HIS Tag), a highly advanced and meticulously crafted protein that is designed to meet the most demanding requirements of modern scientific research. This protein is a result of cutting-edge recombinant technology and is specifically engineered to provide exceptional performance and reliability in a wide range of applications.

The Recombinant HIV-1 (Group M, Subtype A, Isolate 92RW020) Envelope Glycoprotein GP160 Protein (GP120 Subunit) (HIS Tag) is a highly purified and fully characterized protein that is produced using state-of-the-art techniques. It is a critical component of many research projects that aim to understand the molecular mechanisms of HIV-1 infection and develop effective treatments for this devastating disease.

This protein is characterized by its exceptional purity, high stability, and outstanding biological activity. It is produced in a highly controlled environment to ensure that it meets the most stringent quality standards. The HIS tag attached to the protein allows for easy purification and detection, making it an ideal choice for a wide range of research applications.

In summary, the Recombinant HIV-1 (Group M, Subtype A, Isolate 92RW020) Envelope Glycoprotein GP160 Protein (GP120 Subunit) (HIS Tag) is a highly advanced and reliable protein that is designed to meet the most demanding requirements of modern scientific research. It is an essential tool for researchers who are working to understand the molecular mechanisms of HIV-1 infection and develop effective treatments for this devastating disease.
View full details